The short answer
PubMed indexes roughly 519 DSIP records, spanning from the 1977 isolation to the present. Despite that volume the central claim remains unresolved, and the field's own 2006 review describes it as a riddle. Publication count here reflects sustained interest rather than accumulated confirmation.
Key facts
- Indexed PubMed records
- ~519
- First publication
- March 1977 (PNAS)
- Sequence paper
- 1978, Pflügers Arch
- Key review
- Kovalzon 2006, J Neurochem
- Review's verdict
- 'A still unresolved riddle'
- Registered clinical trials
- None established
- Regulatory review
- None
A large literature and a small conclusion
519 records is substantially more than Selank's 135 or Semax's 231, and comparable to well-studied research compounds. Yet the question that prompted the first paper, whether this peptide has a role in sleep, has no settled answer. That combination is the most useful thing to know about the literature before reading any individual paper in it.
Why volume is not weight
Papers accumulate for many reasons. A tractable question with a clear answer generates a burst of work and then stops. An interesting question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. DSIP's publication profile looks much more like the second pattern, and Kovalzon's 2006 title states the field's assessment explicitly.
Research material referenced
DSIP 5mg, third-party HPLC tested
The shape of the work
The literature spans the original isolation and sequencing, a large body of animal work examining sleep and other reported activities, and reviews periodically taking stock. What it does not contain is the gene, precursor and receptor work that would have converted the hypothesis into biology, and it contains no established programme of registered clinical trials.
The 1970s context
DSIP emerged during a period of intense interest in humoral sleep factors: the idea that sleep is driven by circulating substances that accumulate during waking. Several candidates were proposed in that era and most did not survive as sleep factors, though some found other roles. Reading DSIP as part of that cohort, rather than in isolation, makes its trajectory less surprising.
How to search it
PubMed indexes the field under 'delta sleep-inducing peptide'; the INN emideltide surfaces regulatory records the abbreviation misses. Filtering by publication type separates reviews from primary research, and checking the model organism is the fastest way to establish what kind of evidence a paper offers. For DSIP specifically, checking whether a paper administers the peptide or merely measures it is the most informative single question.
Frequently asked questions
Are there clinical trials of DSIP?
No established programme of registered interventional trials, and no regulator has reviewed it.
Which paper should I read first?
Kovalzon's 2006 review in the Journal of Neurochemistry, PMID 16539679. It is the clearest available account of what has and has not been established.
Does 519 papers mean DSIP is well established?
No. Publication volume reflects sustained interest in an unresolved question rather than accumulated confirmation of an answer.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedKovalzon VM, DSIP: a still unresolved riddle. J Neurochem 2006 (PMID 16539679)pubmed.ncbi.nlm.nih.gov
- PubMedSchoenenberger GA et al., Characterization of a delta-EEG (sleep)-inducing peptide. PNAS 1977 (PMID 265572)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- DSIP Regulatory StatusDSIP holds no marketing authorisation anywhere. It has an INN, emideltide, which is a naming decision rather than an approval - a distinction worth knowing.
- An Antibody Reports What It Binds, Not What Is ThereRIA generated most of the DSIP distribution literature. It measures immunoreactivity - which is a statement about an antibody, not about a molecule.
- What the Antibody Found in Peripheral TissueGraf and Kastin measured DSIP-like material across 12 rat tissues - highest in stomach - then showed chromatography put most of it at a larger size.
- What Adrenalectomy ChangedBjartell 1991 measured immunoreactive DSIP in rat hypothalamus, pituitary and adrenal gland, and examined what removing the adrenals did to it.
- A Question Mark in the Title Is Doing Real WorkGimble 2009 proposed links between DSIP, glucocorticoid-induced leucine zipper, circadian mechanisms and obesity - and framed it as a question.